{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:37:50Z","timestamp":1767890270607,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["R01CA223370"],"award-info":[{"award-number":["R01CA223370"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19 is a highly contagious respiratory infection caused by the SARS-CoV-2 virus. The infected lung epithelial cells secrete a group of chemokines and cytokines, which triggers harmful cytokine storms and hyper-thrombotic responses. Recent studies have proposed that viral-induced senescence is responsible for cytokine release and inflammation in COVID-19 patients. However, it is unknown whether cellular senescence is commonly triggered after viral infection and how inflammation and thrombosis, hyper-activated in these patients, are functionally connected. To address these questions, we conducted a bioinformatics-based meta-analysis using single-cell and bulk RNA sequencing datasets obtained from human patient studies, animal models, and cell lines infected with SARS-CoV-2 and other respiratory viruses. We found that the senescence phenotype is robustly upregulated in most SARS-CoV-2-infected patients, especially in the infected lung epithelial cells. Notably, the upregulation of Tissue factor (F3), a key initiator of the extrinsic blood coagulation pathway, occurs concurrently with the upregulation of the senescence-associated secretory phenotype (SASP) factors. Furthermore, F3 levels are positively correlated with the senescence and hyper-coagulation gene signatures in COVID-19 patients. Together, these data demonstrate the prevalence of senescence in respiratory viral infection and suggest F3 as a critical link between inflammation, thrombosis, and senescence in these disease states.<\/jats:p>","DOI":"10.1038\/s41598-022-23950-y","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:03:41Z","timestamp":1668773021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tissue factor links inflammation, thrombosis, and senescence in COVID-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Dayna","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Min","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeongwu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"10229","key":"23950_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395(10229), 1054\u20131062 (2020).","journal-title":"Lancet"},{"issue":"7816","key":"23950_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583(7816), 437\u2013440 (2020).","journal-title":"Nature"},{"issue":"6485","key":"23950_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485), 1444\u20131448 (2020).","journal-title":"Science"},{"issue":"1","key":"23950_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. COVID-19: Immunopathogenesis and Immunotherapeutics. Signal Transduct. Target Ther. 5(1), 128 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"23950_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","volume":"8","author":"I Huang","year":"2020","unstructured":"Huang, I. & Pranata, R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J. Intensiv. Care 8, 36 (2020).","journal-title":"J. Intensiv. Care"},{"key":"23950_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab, D. et al. The COVID-19 cytokine storm; What we know so far. Front. Immunol. 11, 1446 (2020).","journal-title":"Front. Immunol."},{"issue":"6","key":"23950_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 20(6), 355\u2013362 (2020).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"23950_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383(2), 120\u2013128 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"23950_CR9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ajh.25982","volume":"95","author":"TC Hanff","year":"2020","unstructured":"Hanff, T. C. et al. Thrombosis in COVID-19. Am. J. Hematol. 95(12), 1578\u20131589 (2020).","journal-title":"Am. J. Hematol."},{"issue":"12","key":"23950_CR10","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jiph.2020.07.014","volume":"13","author":"H Ejaz","year":"2020","unstructured":"Ejaz, H. et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health 13(12), 1833\u20131839 (2020).","journal-title":"J. Infect. Public Health"},{"issue":"6552","key":"23950_CR11","doi-asserted-by":"publisher","first-page":"eabe832","DOI":"10.1126\/science.abe4832","volume":"373","author":"CD Camell","year":"2021","unstructured":"Camell, C. D. et al. Senolytics reduce coronavirus-related mortality in old mice. Science 373(6552), eabe832 (2021).","journal-title":"Science"},{"issue":"7884","key":"23950_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","volume":"599","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 599(7884), 283\u2013289 (2021).","journal-title":"Nature"},{"issue":"4","key":"23950_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: Defining a path forward. Cell 179(4), 813\u2013827 (2019).","journal-title":"Cell"},{"key":"23950_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P. et al. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118 (2010).","journal-title":"Annu. Rev. Pathol."},{"issue":"10229","key":"23950_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395(10229), 1033\u20131034 (2020).","journal-title":"Lancet"},{"issue":"6","key":"23950_CR16","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","volume":"193","author":"C Wu","year":"2014","unstructured":"Wu, C. et al. IFN-gamma primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b. J. Immunol. 193(6), 3036\u20133044 (2014).","journal-title":"J. Immunol."},{"issue":"6","key":"23950_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26(6), 842\u2013844 (2020).","journal-title":"Nat. Med."},{"issue":"43","key":"23950_CR18","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102(43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"23950_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"23950_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","volume":"50","author":"M Bautista-Vargas","year":"2020","unstructured":"Bautista-Vargas, M., Bonilla-Abadia, F. & Canas, C. A. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19. J. Thromb. Thrombolysis 50(3), 479\u2013483 (2020).","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"23950_CR21","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","volume":"29","author":"S Butenas","year":"2009","unstructured":"Butenas, S., Orfeo, T. & Mann, K. G. Tissue factor in coagulation: Which? Where? When?. Arterioscler. Thromb. Vasc. Biol. 29(12), 1989\u20131996 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"23950_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover, S. P. & Mackman, N. Tissue factor: An essential mediator of hemostasis and trigger of Thrombosis. Arterioscler. Thromb. Vasc. Biol. 38(4), 709\u2013725 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"23950_CR23","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.isci.2021.102151","volume":"24","author":"E Wyler","year":"2021","unstructured":"Wyler, E. et al. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience 24(3), 102151 (2021).","journal-title":"iScience"},{"issue":"3","key":"23950_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2021.01.017","volume":"54","author":"DA Hoagland","year":"2021","unstructured":"Hoagland, D. A. et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity 54(3), 557-570 e5 (2021).","journal-title":"Immunity"},{"issue":"8","key":"23950_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","volume":"38","author":"RL Chua","year":"2020","unstructured":"Chua, R. L. et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 38(8), 970\u2013979 (2020).","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"23950_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1542\/pir.35.12.519","volume":"35","author":"G Piedimonte","year":"2014","unstructured":"Piedimonte, G. & Perez, M. K. Respiratory syncytial virus infection and bronchiolitis. Pediatr. Rev. 35(12), 519\u2013530 (2014).","journal-title":"Pediatr. Rev."},{"key":"23950_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fcimb.2020.00277","volume":"10","author":"H Ganjian","year":"2020","unstructured":"Ganjian, H. et al. Rhinovirus and innate immune function of airway Epithelium. Front. Cell. Infect. Microbiol. 10, 277 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"23950_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bj.2018.08.004","volume":"41","author":"L Denney","year":"2018","unstructured":"Denney, L. & Ho, L. P. The role of respiratory epithelium in host defence against influenza virus infection. Biomed. J. 41(4), 218\u2013233 (2018).","journal-title":"Biomed. J."},{"issue":"5","key":"23950_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5), 1036-1045 e9 (2020).","journal-title":"Cell"},{"issue":"1","key":"23950_CR30","doi-asserted-by":"publisher","first-page":"e02880","DOI":"10.1128\/mBio.02880-19","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Cell-to-cell variation in defective virus expression and effects on host responses during influenza virus infection. mBio 11(1), e02880-19 (2020).","journal-title":"mBio"},{"issue":"20","key":"23950_CR31","doi-asserted-by":"publisher","first-page":"e00559","DOI":"10.1128\/JVI.00559-19","volume":"93","author":"I Ramos","year":"2019","unstructured":"Ramos, I. et al. Innate immune response to influenza virus at single-cell resolution in human epithelial cells revealed paracrine induction of interferon lambda 1. J Virol. 93(20), e00559-19 (2019).","journal-title":"J Virol."},{"issue":"18","key":"23950_CR32","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1073\/pnas.87.18.7095","volume":"87","author":"NS Key","year":"1990","unstructured":"Key, N. S. et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc. Natl. Acad. Sci. U. S. A. 87(18), 7095\u20137099 (1990).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"23950_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","volume":"115","author":"NT Funderburg","year":"2010","unstructured":"Funderburg, N. T. et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: Relationship to in vivo coagulation and immune activation. Blood 115(2), 161\u20137 (2010).","journal-title":"Blood"},{"issue":"9400","key":"23950_CR34","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","volume":"362","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T. W. et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: A study in rhesus monkeys. Lancet 362(9400), 1953\u20131958 (2003).","journal-title":"Lancet"},{"issue":"10","key":"23950_CR35","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1182\/blood-2001-12-0237","volume":"99","author":"IM Francischetti","year":"2002","unstructured":"Francischetti, I. M. et al. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa\/tissue factor complex. Blood 99(10), 3602\u20133612 (2002).","journal-title":"Blood"},{"issue":"4","key":"23950_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10585-020-10036-0","volume":"37","author":"T Barboza","year":"2020","unstructured":"Barboza, T. et al. Development of (131) I-ixolaris as a theranostic agent: Metastatic melanoma preclinical studies. Clin. Exp. Metastasis 37(4), 489\u2013497 (2020).","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"23950_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.RES.82.1.39","volume":"82","author":"P Golino","year":"1998","unstructured":"Golino, P. et al. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ. Res. 82(1), 39\u201346 (1998).","journal-title":"Circ. Res."},{"issue":"1","key":"23950_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/hc2601.091386","volume":"104","author":"A Lee","year":"2001","unstructured":"Lee, A. et al. Dose-response study of recombinant factor VIIa\/tissue factor inhibitor recombinant nematode anticoagulant protein C2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 104(1), 74\u201378 (2001).","journal-title":"Circulation"},{"issue":"12","key":"23950_CR39","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6(12), 2853\u20132868 (2008).","journal-title":"PLoS Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23950-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:19:35Z","timestamp":1668773975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23950-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23950"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23950-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19842"}}